PL310821A1 - Aluminium containing pharmaceutical preparation of controllable active substance release - Google Patents

Aluminium containing pharmaceutical preparation of controllable active substance release

Info

Publication number
PL310821A1
PL310821A1 PL94310821A PL31082194A PL310821A1 PL 310821 A1 PL310821 A1 PL 310821A1 PL 94310821 A PL94310821 A PL 94310821A PL 31082194 A PL31082194 A PL 31082194A PL 310821 A1 PL310821 A1 PL 310821A1
Authority
PL
Poland
Prior art keywords
active substance
pharmaceutical preparation
containing pharmaceutical
substance release
aluminium containing
Prior art date
Application number
PL94310821A
Other languages
English (en)
Inventor
Istvan Racz
Janos Plachy
Istvan Antal
Original Assignee
Synepos Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9300744A external-priority patent/HUT70038A/hu
Application filed by Synepos Ag filed Critical Synepos Ag
Publication of PL310821A1 publication Critical patent/PL310821A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL94310821A 1993-03-16 1994-03-16 Aluminium containing pharmaceutical preparation of controllable active substance release PL310821A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9300744A HUT70038A (en) 1992-03-16 1993-03-16 2-oxoquinolines, pharmaceutical compositions containing them, and the process for preparing thereof
PCT/EP1994/000829 WO1994021268A1 (en) 1993-03-16 1994-03-16 Aluminium containing pharmaceutical preparation with controlled release

Publications (1)

Publication Number Publication Date
PL310821A1 true PL310821A1 (en) 1996-01-08

Family

ID=10983353

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94310821A PL310821A1 (en) 1993-03-16 1994-03-16 Aluminium containing pharmaceutical preparation of controllable active substance release

Country Status (7)

Country Link
EP (1) EP0689445A1 (xx)
JP (1) JPH08507775A (xx)
AU (1) AU6426994A (xx)
CA (1) CA2158437A1 (xx)
FI (1) FI954348A (xx)
PL (1) PL310821A1 (xx)
WO (1) WO1994021268A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424675A1 (de) * 1994-07-13 1996-01-18 Bayer Ag Antacidazubereitung mit verbessertem Sicherheitsprofil
CA2477964A1 (en) * 2002-03-04 2003-09-12 Medrx Co., Ltd. Liquid matrix transforming its phase in living body and oral liquid preparation
JP6466906B2 (ja) 2013-03-15 2019-02-06 マリンクロット ホスピタル プロダクツ アイピー リミテッド パルス的および連続的流れ制御による治療用ガス送達装置
CN114917198B (zh) * 2022-06-22 2023-05-12 海南妙音春制药有限公司 一种铝碳酸镁咀嚼片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579634A (en) * 1968-04-18 1971-05-18 Garland Richard Brown Novel antacid compositions and methods for their administration
US3591680A (en) * 1969-11-17 1971-07-06 Smith Kline French Lab Concentrated antacid compositions and method of producing antacid activity
FR2153174B1 (xx) * 1971-09-23 1976-04-16 Biotherax Lab
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida
GB2201594B (en) * 1986-06-24 1991-02-13 Istvan Racz Production of acid binding pharmaceutical preparations
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations

Also Published As

Publication number Publication date
WO1994021268A1 (en) 1994-09-29
FI954348A (fi) 1995-11-15
CA2158437A1 (en) 1994-09-29
JPH08507775A (ja) 1996-08-20
EP0689445A1 (en) 1996-01-03
FI954348A0 (fi) 1995-09-15
AU6426994A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
PL313386A1 (en) Novel pearls ensuring controllable drug release and pharmaceutic preparation containing them
EP0741580A4 (en) CONTROLLED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCES FOR IMMUNOTHERAPY
HRP920229A2 (en) Release of medicinal substances and preparation process therefor
IL105966A (en) Preparation of clavulanic acid
AU7208494A (en) Controlled release of pharmaceutically active substances from coacervate microcapsules
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
IL105222A0 (en) Cyclohex-1-ene compounds and pharmaceutical compositions containing them
ZA988718B (en) Drug formulation having controlled release of active compound
IL116771A (en) 9-Substituted 2-(2-n-alkoxyphenyl) purin-6-one compounds their preparation and pharmaceutical compositions containing them
PL299369A1 (en) Novel epoxy compounds, method of obtainining them and pharmaceutical preparation containing them
SG43083A1 (en) Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
AP9300581A0 (en) Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use
PL327584A1 (en) Active substance quckly releasing tablet containing tolphenamica acid or its pharmaceutically acceptable salt
PL310821A1 (en) Aluminium containing pharmaceutical preparation of controllable active substance release
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
HK1016180A1 (en) Process for the preparation of anti-malarial drugs
IL117152A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparation based on these compounds and medicaments containing them
AU5560694A (en) Pharmaceutical formulations of ibuprofen
GB9304745D0 (en) Use of pharmaceutical formulations
HUT74076A (en) Pharmaceutical preparation containing penciclorin for the treatment of post-therapeutic neuralgia
IL117179A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparations based on these compounds and medicaments containing them
IL103411A0 (en) Pharmaceutical formulation for controlled release of melatonin
IL105870A0 (en) Pharmaceutical soft capsules containing lysine clonixinate and their preparation
IL108985A0 (en) Controlled release pharmaceutical compositions containing aluminium compounds and their preparation